Advertisement

Research Article Free access | 10.1172/JCI116579

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

H Ito, Y Hirata, S Adachi, M Tanaka, M Tsujino, A Koike, A Nogami, F Murumo, and M Hiroe

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Ito, H. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Hirata, Y. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Adachi, S. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Tanaka, M. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Tsujino, M. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Koike, A. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Nogami, A. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Murumo, F. in: PubMed | Google Scholar

Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

Find articles by Hiroe, M. in: PubMed | Google Scholar

Published July 1, 1993 - More info

Published in Volume 92, Issue 1 on July 1, 1993
J Clin Invest. 1993;92(1):398–403. https://doi.org/10.1172/JCI116579.
© 1993 The American Society for Clinical Investigation
Published July 1, 1993 - Version history
View PDF
Abstract

To elucidate the cellular mechanism by which angiotensin II (ANG II) induces cardiac hypertrophy, we investigated the possible autocrine/paracrine role of endogenous endothelin-1 (ET-1) in ANG II-induced hypertrophy of neonatal rat cardiomyocytes by use of synthetic ET-1 receptor antagonist and antisense oligonucleotides to preproET-1 (ppET-1) mRNA. Northern blot analysis and in situ hybridization revealed that ppET-1 mRNA was expressed in cardiomyocytes, but, to a lesser extent, in nonmyocytes as well. ANG II upregulated ppET-1 mRNA level by threefold over control level as early as 30 min, and it stimulated release of immunoreactive ET-1 from cardiomyocytes in a dose- and time-dependent manner. ET-1 stimulated ppET-1 mRNA levels after 30 min in a similar fashion as ANG II. Tetradecanoylphorbol-acetate (10(-7) M) mimicked the effects of ANG II and ET-1 on induction of ppET-1 mRNA. ANG II-induced ppET-1 gene expression was completely blocked by protein kinase C inhibitor H-7 or by down-regulation of endogenous protein kinase C by pretreatment with phorbol ester. ET-1 and ANG II stimulated twofold increase [3H]leucine incorporation into cardiomyocytes, whose effects were similarly and dose dependently inhibited by endothelin A receptor antagonist (BQ123). Introduction of antisense sequence against coding region of ppET-1 mRNA into cardiomyocytes resulted in complete blockade with ppET-1 mRNA levels and [3H]leucine incorporation stimulated by ANG II. These results suggest that endogenous ET-1 locally generated and secreted by cardiomyocytes may contribute to ANG II-induced cardiac hypertrophy via an autocrine/paracrine fashion.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (July 1, 1993): No description
Advertisement
Advertisement